Nexalis Therapeutics Statistics

Total Valuation

ASX:NX1 has a market cap or net worth of AUD 5.82 million. The enterprise value is 6.12 million.

Market Cap	5.82M
Enterprise Value	6.12M

Important Dates

The next estimated earnings date is Friday, May 22, 2026.

Earnings Date	May 22, 2026
Ex-Dividend Date	n/a

Share Statistics

ASX:NX1 has 253.04 million shares outstanding. The number of shares has increased by 1.05% in one year.

Current Share Class	253.04M
Shares Outstanding	253.04M
Shares Change (YoY)	+1.05%
Shares Change (QoQ)	+2.09%
Owned by Insiders (%)	26.32%
Owned by Institutions (%)	4.23%
Float	108.60M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.90
PB Ratio	-6.12
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.78
EV / Sales	6.21
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.69

Current Ratio	0.69
Quick Ratio	0.65
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-10.90

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-86.71%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	234.69%
Weighted Average Cost of Capital (WACC)	5.72%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.92
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +27.78% in the last 52 weeks. The beta is 0.06, so ASX:NX1's price volatility has been lower than the market average.

Beta (5Y)	0.06
52-Week Price Change	+27.78%
50-Day Moving Average	0.02
200-Day Moving Average	0.03
Relative Strength Index (RSI)	51.86
Average Volume (20 Days)	110,057

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:NX1 had revenue of AUD 986,434 and -1.62 million in losses. Loss per share was -0.01.

Revenue	986,434
Gross Profit	986,434
Operating Income	-1.49M
Pretax Income	-1.62M
Net Income	-1.62M
EBITDA	n/a
EBIT	-1.49M
Loss Per Share	-0.01

Full Income Statement

Balance Sheet

The company has 436,900 in cash and 741,278 in debt, with a net cash position of -304,378 or -0.00 per share.

Cash & Cash Equivalents	436,900
Total Debt	741,278
Net Cash	-304,378
Net Cash Per Share	-0.00
Equity (Book Value)	-950,524
Book Value Per Share	-0.00
Working Capital	-634,032

Full Balance Sheet

Cash Flow

Operating Cash Flow	-888,173
Capital Expenditures	n/a
Depreciation & Amortization	n/a
Net Borrowing	652,501
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -150.85% and -164.10%.

Gross Margin	100.00%
Operating Margin	-150.85%
Pretax Margin	-164.10%
Profit Margin	-164.10%
EBITDA Margin	n/a
EBIT Margin	-150.85%
FCF Margin	n/a

Dividends & Yields

ASX:NX1 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.05%
Shareholder Yield	-1.05%
Earnings Yield	-27.81%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ASX:NX1 has an Altman Z-Score of -17.17 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-17.17
Piotroski F-Score	2